It is interesting to note that the methylation status of Pcdh10 may be able to predict the response of lymphomas to doxorubicin (Narayan et al. 2013), a common chemotherapeutic drug used to treat a variety of human cancers. This evidence concerns the gene PCDH10 and lymphoma.